Adamas Wins FDA OK for the First and Only Drug for Parkinson's Dyskinesia Drug Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Mark Terry, BioSpace.com… Source: BioSpace You Might Also Like Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock May 10, 2017 All Systems Go: Johnson & Johnson Reaches Out for Second Ionis GI Drug November 15, 2017 ESSA Pharma Provides Business Update And Announces Financial Results For The First Quarter Ended December 31, 2016 February 12, 2017
Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock May 10, 2017
ESSA Pharma Provides Business Update And Announces Financial Results For The First Quarter Ended December 31, 2016 February 12, 2017
